Court prohibited manufacturing and sales of Glivec generics for GIST

The court accepted the Glivec’s use patent of gastrointestinal stromal tumor(GIST), and ordered to prohibit sales and manufacturing of its generics for the indication.

The 12^th Civil Department, Seoul Central District Court, ruled the partial winning of the plaintiff at the lawsuit on the merits filed by Novartis against Boryung Pharm on the 15^th.

The court accepted the Glivec’s GIST use pa...